CLINICAL EFFICACY OF SEQUENTIAL TREATMENTS IN METASTATIC KRASG12C-MUTATED COLORECTAL CANCER
This multicenter clinical trial evaluated the clinical efficacy of sequential treatments in patients with metastatic colorectal cancer with G12C mutation of the KRAS gene who received intensive first-line double or triple first-line chemotherapy (including irinotecan- or oxaliplatin-based chemotherapy). In the development of the trial, only moderate overall response rates were observed with first-line double or […]
